European Heart Journal Advance Access originally published online on June 2, 2005
European Heart Journal 2005 26(16):1640-1646; doi:10.1093/eurheartj/ehi340
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers
1Department of Epidemiology, The German Centre for Research on Ageing, University of Heidelberg, Germany
2Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Austria
3Department of Internal Medicine II—Cardiology, University of Ulm Medical Center, Robert-Koch Str. 8, 89081 Ulm, Germany
Received 22 December 2004; revised 20 April 2005; accepted 28 April 2005; online publish-ahead-of-print 2 June 2005.
* Corresponding author. Tel: +49 731 500 24465; fax: +49 731 500 33872. E-mail address: wolfgang.koenig{at}medizin.uni-ulm.de
See page 1579 for the editorial comment on this article (doi:10.1093/eurheartj/ehi374)
Aims We investigated the association of serum adiponectin concentrations with the risk of coronary heart disease (CHD) after careful adjustment for other established risk factors. In addition, we investigated the association between adiponectin levels and established sociodemographic and laboratory risk markers for CHD.
Methods and results Three hundred and twelve patients aged 40–68 with angiographically confirmed stable CHD and 476 age- and gender-matched controls were included in this case–control study. Adiponectin serum concentrations (adiponectin, R&D Systems, Wiesbaden, Germany), markers of inflammation and haemostasis, and an extensive lipid profile were determined. Adiponectin serum concentrations were lower in CHD patients when compared with age- and gender-matched controls, both in men (median 4.95 vs. 5.58 µmol/L, P=0.004) and in women (median 9.64 vs. 11.60 µmol/L, P=0.018). Adiponectin was strongly correlated with lipoproteins and apolipoproteins, in particular HDL-cholesterol (HDL-C), and to a lesser degree with markers of inflammation such as C-reactive protein, IL-6, or markers of coagulation or fibrinolysis. When compared with subjects with adiponectin serum concentrations in the lower quintile, the OR for CHD was 0.52 (95% CI 0.28–0.95) in the upper one after adjustment for covariates (P<0.007 for trend). After additional adjustment for HDL-C the association was strongly reduced, reflecting the close association between adiponectin and HDL-C.
Conclusion Adiponectin serum concentrations may have an important role in the development of CHD. The protective effect of high serum concentration may partly be mediated by effects on the metabolism of lipoproteins, especially on the metabolism of HDL.
Key Words: Adiponectin • Coronary heart disease • Inflammation • Lipids • Case–control study
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Adiponectin and high-density lipoprotein: a metabolic association through thick and thin
- Peter P. Toth
EHJ 2005 26: 1579-1581.[Extract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  L. M Ritland, D L. Alekel, O. A Matvienko, K. B Hanson, J. W Stewart, L. N Hanson, M. B Reddy, M. D Van Loan, and U. Genschel Centrally located body fat is related to appetitive hormones in healthy postmenopausal women. Eur. J. Endocrinol., June 1, 2008; 158(6): 889 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. von Eynatten, A. Hamann, D. Twardella, P. P. Nawroth, H. Brenner, and D. Rothenbacher Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease Eur. Heart J., May 2, 2008; 29(10): 1307 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Abel, S. E. Litwin, and G. Sweeney Cardiac Remodeling in Obesity Physiol Rev, April 1, 2008; 88(2): 389 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K M Choi, J S Lee, E J Kim, S H Baik, H S Seo, D S Choi, D J Oh, and C G Park Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease Eur. J. Endocrinol., February 1, 2008; 158(2): 203 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. S. Packard and P. Libby Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction Clin. Chem., January 1, 2008; 54(1): 24 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Merkle, J. Wohrle, O. Grebe, T. Nusser, M. Kunze, H. A Kestler, M. Kochs, and V. Hombach Assessment of myocardial perfusion for detection of coronary artery stenoses by steady-state, free-precession magnetic resonance first-pass imaging Heart, November 1, 2007; 93(11): 1381 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cesari, K. Narkiewicz, R. De Toni, E. Aldighieri, C. J. Williams, and G. P. Rossi Heritability of Plasma Adiponectin Levels and Body Mass Index in Twins J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3082 - 3088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Wannamethee, P. H. Whincup, L. Lennon, and N. Sattar Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure Arch Intern Med, July 23, 2007; 167(14): 1510 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lin, F. B. Hu, and G. Curhan Serum Adiponectin and Renal Dysfunction in Men With Type 2 Diabetes Diabetes Care, February 1, 2007; 30(2): 239 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Frystyk, C. Berne, L. Berglund, K. Jensevik, A. Flyvbjerg, and B. Zethelius Serum Adiponectin Is a Predictor of Coronary Heart Disease: A Population-Based 10-Year Follow-Up Study in Elderly Men J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 571 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Laughlin, E. Barrett-Connor, S. May, and C. Langenberg Association of Adiponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo Study Am. J. Epidemiol., January 15, 2007; 165(2): 164 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pilz, H. Mangge, B. Wellnitz, U. Seelhorst, B. R. Winkelmann, B. Tiran, B. O. Boehm, and W. Marz Adiponectin and Mortality in Patients Undergoing Coronary Angiography J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4277 - 4286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Koenig, N. Khuseyinova, J. Baumert, C. Meisinger, and H. Lowel Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men: Results From the 18-Year Follow-Up of a Large Cohort From Southern Germany J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1369 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Menon, L. Li, X. Wang, T. Greene, V. Balakrishnan, M. Madero, A. A. Pereira, G. J. Beck, J. W. Kusek, A. J. Collins, et al. Adiponectin and Mortality in Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2599 - 2606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-H. Gannage-Yared, S. Khalife, M. Semaan, F. Fares, S. Jambart, and G. Halaby Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur. J. Endocrinol., July 1, 2006; 155(1): 167 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Herder, H. Hauner, B. Haastert, K. Rohrig, W. Koenig, H. Kolb, S. Muller-Scholze, B. Thorand, R. Holle, and W. Rathmann Hypoadiponectinemia and Proinflammatory State: Two Sides of the Same Coin?: Results From the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4) Diabetes Care, July 1, 2006; 29(7): 1626 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bansal, V. Charlton-Menys, P. Pemberton, P. McElduff, J. Oldroyd, A. Vyas, A. Koudsi, P. E. Clayton, J. K. Cruickshank, and P. N. Durrington Adiponectin in Umbilical Cord Blood Is Inversely Related to Low-Density Lipoprotein Cholesterol But Not Ethnicity J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2244 - 2249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. von Eynatten, A. Hamann, D. Twardella, P. P. Nawroth, H. Brenner, and D. Rothenbacher Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart Disease Clin. Chem., May 1, 2006; 52(5): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Toth Adiponectin and high-density lipoprotein: a metabolic association through thick and thin Eur. Heart J., August 2, 2005; 26(16): 1579 - 1581. [Full Text] [PDF]
|
|